Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-07

Clinical Trial Update: Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a first-line combination of irinotecan, fluorouracil, leucovorin, and oxaliplatin for metastatic colorectal cancer; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (Adrucil) (5-Fluorouracil)
  • Irinotecan (Camptosar) (Irinotecan)
  • Leucovorin (folinic acid)
  • Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED